1887

Abstract

This study was conducted as part of the Argentinean Influenza and other Respiratory Viruses Surveillance Network, in the context of the Global Influenza Surveillance carried out by the World Health Organization (WHO). The objective was to study the activity and the antigenic and genomic characteristics of circulating viruses for three consecutive seasons (2010, 2011 and 2012) in order to investigate the emergence of influenza viral variants. During the study period, influenza virus circulation was detected from January to December. Influenza A and B, and all current subtypes of human influenza viruses, were present each year. Throughout the 2010 post-pandemic season, influenza A(H1N1)pdm09, unexpectedly, almost disappeared. The haemagglutinin (HA) of the A(H1N1)pdm09 viruses studied were segregated in a different genetic group to those identified during the 2009 pandemic, although they were still antigenically closely related to the vaccine strain A/California/07/2009. Influenza A(H3N2) viruses were the predominant strains circulating during the 2011 season, accounting for nearly 76 % of influenza viruses identified. That year, all HA sequences of the A(H3N2) viruses tested fell into the A/Victoria/208/2009 genetic clade, but remained antigenically related to A/Perth/16/2009 (reference vaccine recommended for this three-year period). A(H3N2) viruses isolated in 2012 were antigenically closely related to A/Victoria/361/2011, recommended by the WHO as the H3 component for the 2013 Southern Hemisphere formulation. B viruses belonging to the B/Victoria lineage circulated in 2010. A mixed circulation of viral variants of both B/Victoria and B/Yamagata lineages was detected in 2012, with the former being predominant. A(H1N1)pdm09 viruses remained antigenically closely related to the vaccine virus A/California/7/2009; A(H3N2) viruses continually evolved into new antigenic clusters and both B lineages, B/Victoria/2/87-like and B/Yamagata/16/88-like viruses, were observed during the study period. The virological surveillance showed that the majority of the circulating strains during the study period were antigenically related to the corresponding Southern Hemisphere vaccine strains except for the 2012 A(H3N2) viruses.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.076208-0
2014-12-01
2019-11-12
Loading full text...

Full text loading...

/deliver/fulltext/jmm/63/12/1626.html?itemId=/content/journal/jmm/10.1099/jmm.0.076208-0&mimeType=html&fmt=ahah

References

  1. AMH ( 2010a;). Boletín Epidemiológico Anual, 52–54. [Accessed 22 August 2013]. . http://www.msal.gov.ar/saladesituacion/boletines_epidemiologia/pdfs/BEPANUAL_2010.pdf
  2. AMH ( 2010b;). Infecciones Respiratorias Agudas. Actualización de la modalidad de vigilancia y recomendaciones para su prevención. Vigilancia Epidemiológica. [Accessed 10 September 2014]. . http://www.msal.gov.ar/saladesituacion/boletines_epidemiologia/pdfs/BEPANUAL_2010.pdf
  3. AMH ( 2011;). Campaña Nacional de Vacunación Antigripal, Argentina 7. [Accessed 21 August 2013]. . http://www.femeba.org.ar/fundacion/documentos/0000000241.pdf
  4. AMH ( 2012a;). Actualización de Recomendaciones Infecciones Respiratorias Agudas Argentina. [Accessed 10 September 2014]. . http://www.msal.gov.ar/images/stories/epidemiologia/pdf/actualizacion-recomendaciones-IRA-2012.pdf
  5. AMH (2012b). Boletín Integrado de Vigilancia 105, SE 3, 50–51. [Accessed 22 August 2013]. . http://www.msal.gov.ar/images/stories/boletines/BoletinIntegradoDeVigilanciaVersion_N105-SE03.pdf
  6. AMH ( 2012c;). Boletín Integrado de Vigilancia 151, SE 51, 31–34. [Accessed 22 August 2013]. . http://www.msal.gov.ar/images/stories/boletines/boletin-vigilancia_n151-se51.pdf
  7. AMH ( 2013a;). Actualización de Recomendaciones Infecciones Respiratorias Agudas Argentina. [Accessed 10 September 2014]. . http://www.msal.gov.ar/images/stories/bes/graficos/0000000055cnt-recomendaciones-infecciones-respiratorias-2013.pdf
  8. AMH ( 2013b;). Vacunación Antigripal, Argentina 8. [Accessed 21 August 2013]. . http://www.msal.gov.ar/images/stories/bes/graficos/0000000443cnt-2013-10_lineamientos_antigripal.pdf
  9. AMH ( 2014;). Argentinean Ministry of Health. Vacunación Antigripal, Argentina 2014, 16. [Accessed 16 September 2014]. . http://www.msal.gov.ar/images/stories/bes/graficos/0000000450cnt-2014-03_lineamientos-gripe-2014-final.pdf
  10. Azziz-Baumgartner E., Cabrera A. M., Chang L., Calli R., Kusznierz G., Baez C., Yedlin P., Zamora A. M., Cuezzo R.. & other authors ( 2012;). Mortality, severe acute respiratory infection, and influenza-like illness associated with influenza A(H1N1)pdm09 in Argentina, 2009. . PLoS ONE 7:, e47540. [CrossRef][PubMed]
    [Google Scholar]
  11. Balanzat A. M., Hertlein C., Apezteguia C., Bonvehi P., Cámera L., Gentile A., Rizzo O., Gómez-Carrillo M., Coronado F.. & other authors ( 2012;). An analysis of 332 fatalities infected with pandemic 2009 influenza A (H1N1) in Argentina. . PLoS ONE 7:, e33670. [CrossRef][PubMed]
    [Google Scholar]
  12. Barr I. G., McCauley J., Cox N., Daniels R., Engelhardt O. G., Fukuda K., Grohmann G., Hay A., Kelso A.. & other authors ( 2010;). Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses: basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009-2010 northern hemisphere season. . Vaccine 28:, 1156–1167. [CrossRef][PubMed]
    [Google Scholar]
  13. CDC ( 2013;). Overview of Influenza Surveillance in the United States. [Accessed 1 October 2014]. . http://www.cdc.gov/flu/pdf/weekly/overview.pdf
  14. Cox N. J., Brammer T. L., Regnery H. L.. ( 1994;). Influenza: global surveillance for epidemic and pandemic variants. . Eur J Epidemiol 10:, 467–470. [CrossRef][PubMed]
    [Google Scholar]
  15. Estenssoro E., Ríos F. G., Apezteguía C., Reina R., Neira J., Ceraso D. H., Orlandi C., Valentini R., Tiribelli N.. & other authors ( 2010;). Pandemic 2009 influenza A in Argentina: a study of 337 patients on mechanical ventilation. . Am J Respir Crit Care Med 182:, 41–48. [CrossRef][PubMed]
    [Google Scholar]
  16. Garten R. J., Davis C. T., Russell C. A., Shu B., Lindstrom S., Balish A., Sessions W. M., Xu X., Skepner E.. & other authors ( 2009;). Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. . Science 325:, 197–201. [CrossRef][PubMed]
    [Google Scholar]
  17. Giglio N., Gentile A., Lees L., Micone P., Armoni J., Reygrobellet C., Crépey P.. ( 2012;). Public health and economic benefits of new pediatric influenza vaccination programs in Argentina. . Hum Vaccin Immunother 8:, 312–322. [CrossRef][PubMed]
    [Google Scholar]
  18. Kanegae Y., Sugita S., Endo A., Ishida M., Senya S., Osako K., Nerome K., Oya A.. ( 1990;). Evolutionary pattern of the hemagglutinin gene of influenza B viruses isolated in Japan: cocirculating lineages in the same epidemic season. . J Virol 64:, 2860–2865.[PubMed]
    [Google Scholar]
  19. Klimov A. I., Garten R., Russell C., Barr I. G., Besselaar T. G., Daniels R., Engelhardt O. G., Grohmann G., Itamura S.. & other authors ( 2012;). WHO recommendations for the viruses to be used in the 2012 Southern Hemisphere Influenza Vaccine: epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from February to September 2011. . Vaccine 30:, 6461–6471. [CrossRef][PubMed]
    [Google Scholar]
  20. Libster R., Bugna J., Coviello S., Hijano D. R., Dunaiewsky M., Reynoso N., Cavalieri M. L., Guglielmo M. C., Areso M. S.. & other authors ( 2010;). Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Argentina. . N Engl J Med 362:, 45–55. [CrossRef][PubMed]
    [Google Scholar]
  21. Lin Y. P., Gregory V., Collins P., Kloess J., Wharton S., Cattle N., Lackenby A., Daniels R., Hay A.. ( 2010;). Neuraminidase receptor binding variants of human influenza A(H3N2) viruses resulting from substitution of aspartic acid 151 in the catalytic site: a role in virus attachment. ? J Virol 84:, 6769–6781. [CrossRef][PubMed]
    [Google Scholar]
  22. Lin Y. P., Xiong X., Wharton S. A., Martin S. R., Coombs P. J., Vachieri S. G., Christodoulou E., Walker P. A., Liu J.. & other authors ( 2012;). Evolution of the receptor binding properties of the influenza A(H3N2) hemagglutinin. . Proc Natl Acad Sci U S A 109:, 21474–21479. [CrossRef][PubMed]
    [Google Scholar]
  23. Matrosovich M., Matrosovich T., Carr J., Roberts N. A., Klenk H. D.. ( 2003;). Overexpression of the α-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors. . J Virol 77:, 8418–8425. [CrossRef][PubMed]
    [Google Scholar]
  24. McCullers J. A., Saito T., Iverson A. R.. ( 2004;). Multiple genotypes of influenza B virus circulated between 1979 and 2003. . J Virol 78:, 12817–12828. [CrossRef][PubMed]
    [Google Scholar]
  25. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team ( 2009;). Emergence of a novel swine-origin influenza A (H1N1) virus in humans. . N Engl J Med 360:, 2605–2615. [CrossRef][PubMed]
    [Google Scholar]
  26. Rota P. A., Wallis T. R., Harmon M. W., Rota J. S., Kendal A. P., Nerome K.. ( 1990;). Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983. . Virology 175:, 59–68. [CrossRef][PubMed]
    [Google Scholar]
  27. Rota P. A., Hemphill M. L., Whistler T., Regnery H. L., Kendal A. P.. ( 1992;). Antigenic and genetic characterization of the haemagglutinins of recent cocirculating strains of influenza B virus. . J Gen Virol 73:, 2737–2742. [CrossRef][PubMed]
    [Google Scholar]
  28. Savy V., Baumeister E., Pontoriero A., Armoni J.. ( 2007;). Viral circulation and latitude in Argentina. . Sixth International Conference on Options for the Control of Influenza. http://www.isirv.org/site/images/stories/publication/isirv_Options_VI_Proceedings_Book.pdf
    [Google Scholar]
  29. Tamura K., Dudley J., Nei M., Kumar S.. ( 2007;). mega4: molecular evolutionary genetics analysis (MEGA) software version 4.0. . Mol Biol Evol 24:, 1596–1599. [CrossRef][PubMed]
    [Google Scholar]
  30. Tamura K., Peterson D., Peterson N., Stecher G., Nei M., Kumar S.. ( 2011;). mega5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. . Mol Biol Evol 28:, 2731–2739. [CrossRef][PubMed]
    [Google Scholar]
  31. Van Kerkhove M. D., Mounts A. W., Mall S., Vandemaele K. A., Chamberland M., dos Santos T., Fitzner J., Widdowson M. A., Michalove J.. & other authors ( 2011;). Epidemiologic and virologic assessment of the 2009 influenza A (H1N1) pandemic on selected temperate countries in the Southern Hemisphere: Argentina, Australia, Chile, New Zealand and South Africa. . Influenza Other Respir Viruses 5:, e487–e498. [CrossRef][PubMed]
    [Google Scholar]
  32. WHO ( 2009;). CDC protocol of realtime RT PCR for influenza A(H1N1). [28 April 2009]. .
  33. WHO ( 2010a;). Director-General’s opening statement at virtual press conference: H1N1 in post pandemic period. .
  34. WHO ( 2010b;). Recommended viruses of influenza vaccines for use in the 2011 influenza season (southern hemisphere). . Wkly Epidemiol Rec 85:, 402–412.[PubMed]
    [Google Scholar]
  35. WHO ( 2011;). Recommended composition of influenza vaccines for use in the 2012 southern hemisphere influenza season. . Wkly Epidemiol Rec 86:, 457–468.[PubMed]
    [Google Scholar]
  36. WHO ( 2012a;). Influenza Centre London. National Institute for Medical Research. Report prepared for the WHO annual consultation on the composition of influenza vaccine for the Southern Hemisphere 2013. .
  37. WHO ( 2012b;). Review of the 2012 winter influenza season, southern hemisphere. . Wkly Epidemiol Rec 87:, 422–431.[PubMed]
    [Google Scholar]
  38. WHO ( 2012c;). Recommended composition of influenza virus vaccines for use in the 2012-2013 northern hemisphere influenza season. [23 February 2012]. .
    [Google Scholar]
  39. WHO ( 2012d;). Recommended composition of influenza virus vaccines for use in the 2013 southern hemisphere influenza season. [20 September 2012]. .
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.076208-0
Loading
/content/journal/jmm/10.1099/jmm.0.076208-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error